PreveCeutical Medical Company Description

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity.

PreveCeutical Medical Inc. is headquartered in West Vancouver, Canada.

PreveCeutical Medical Inc.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
CEO	Stephen Van Deventer

Contact Details

Address: 5428 Marine Drive West Vancouver, British Columbia V7W 2R2 Canada
Website	preveceutical.com

Stock Details

Ticker Symbol	PREV
Exchange	Canadian Securities Exchange
Fiscal Year	January - December
Reporting Currency	CAD
ISIN Number	CA74141E1043
SIC Code	2834

Key Executives

Name	Position
Stephen Van Deventer	Chairman, Chief Executive Officer and Chief Financial Officer
Dr. Makarand Jawadekar Ph.D.	Chief Science Officer, President and Director